We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use 51²è¹Ý, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to get information including patient information leaflets (PILs), details on how the medicine can be used (SmPCs) and scientific reports (PARs).
A letter to community pharmacy contractors to set out the detail of the agreed funding arrangements for community pharmacy.
Dear community pharmacy contractors, We write to update you on the…
A 5-year deal setting out how community pharmacy will support delivery of the NHS Long Term Plan.
12 May 2023 Dear community pharmacy contractors, We write to update you on…
22 September 2022 Dear community pharmacy contractors We write to update…
23 August 2021 Dear community pharmacy contractors, We write to update you…
23 February 2020 Dear community pharmacy contractors We write to update…
Executive summary This document provides further information about the…
This publication supports local authority health and wellbeing boards to develop and update pharmaceutical needs assessments (PNAs).
Information for patients, healthcare professionals and developers of new medicines
Helping interpret the Human Medicines (Amendment) Modular Manufacture and Point of Care regulations 2025.
How and when to register updated packaging and information leaflets when new national marketing authorisations have been issued
Report on the public health impact of nurses and midwives, dentists, allied health professionals and pharmacists.
Guidance on how Pharmacy First will help pharmacies support their communities, with information on the new clinical pathways and fee structure.
Resources for pharmacies to achieve Healthy Living Pharmacy (HLP) Level 1 status.
Guidance on how to make reasonable adjustments to help support people with learning disabilities in using pharmacy services.
Report on the service providing sterile, controlled environments for the preparation of injectable medicines into ready-to-administer formats for patients.
If pharmacies wish to ‘pack down’ larger packs of a medicinal product, they need to follow these instructions
Guidance for specialists for initiation of valproate in female patients and for annual review and pregnancy testing to support adherence to pregnancy prevention requirements during the pandemic.
Guidance and advice for community pharmacies in England providing services to people who use drugs and alcohol.
Briefing for local authorities on the increasing role of community pharmacy in public health, working with councils and other community partners.
Sets out opportunities for commissioners and providers to realise community pharmacy’s role in protecting and improving the nation's health.
Information to raise awareness with commissioners and providers of the community pharmacy offer for sexual health, reproductive health and HIV services.
Report on how community pharmacies can improve the prevention, early detection and management of blood pressure.
Interventions that can be made by pharmacy teams, to improve quality of life for older people.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve 51²è¹Ý, we’d like to know more about your visit today. .